NASC on OTC

Can B Corp

Price unavailable

Last updated Oct 16, 2026.

Overview

Compare with Stemtech Corp, HWH International Inc. or Cellyan Biotechnology Co., Ltd, or pick any stock.

  • TickerNASC on OTC
  • IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries
  • HeadquartersFL
  • Incorporated inFL2
  • Business address960 South Broadway, Suite 120, Hicksville, Ny 118012
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

16.6%Gross margin3
-347.3%Operating margin3
-451.7%Net margin3
-67.8%Revenue growth, 20233
-$1.3MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue42¢$1.8M
  • Interest58¢$2.5M
  • Income tax0¢$9.6K

Out of $2.2M in revenue.3 The company lost money this year.

Financial statements

Revenue456783$2.2M in 2023+1656% since 2017
0$2.0M$4.0M$6.0M$8.0M2017: $122.7K$122.7K20172018: $668.6K$668.6K2018+445%2019: $2.3M$2.3M2019+245%2020: $1.7M$1.7M2020−26%2021: $4.6M$4.6M2021+169%2022: $6.7M$6.7M2022+45%2023: $2.2M$2.2M2023−68%
Gross profit456783$358.7K in 2023+358% since 2017
0$1.0M$2.0M$3.0M2017: $78.3K$78.3K20172018: $263.1K$263.1K2018+236%2019: $1.7M$1.7M2019+549%2020: $1.4M$1.4M2020−16%2021: $3.0M$3.0M2021+109%2022: $2.6M$2.6M2022−13%2023: $358.7K$358.7K2023−86%
Operating income456783-$7.5M in 2023+950% since 2017
-$15.0M-$10.0M-$5.0M02017: -$712.8K-$712.8K20172018: -$3.4M-$3.4M2018+379%2019: -$5.9M-$5.9M2019+73%2020: -$7.5M-$7.5M2020+28%2021: -$10.3M-$10.3M2021+36%2022: -$14.2M-$14.2M2022+38%2023: -$7.5M-$7.5M2023−47%
Net income456783-$9.7M in 2023+355% since 2017
-$15.0M-$10.0M-$5.0M02017: -$2.1M-$2.1M20172018: -$4.1M-$4.1M2018+92%2019: -$5.9M-$5.9M2019+43%2020: -$8.9M-$8.9M2020+50%2021: -$12.2M-$12.2M2021+37%2022: -$14.9M-$14.9M2022+23%2023: -$9.7M-$9.7M2023−35%
Fiscal year2017201820192020202120222023
Revenue$122.7K4$668.6K5$2.3M6$1.7M7$4.6M8$6.7M3$2.2M3
Cost of revenue$44.5K4$405.5K5$598.6K6$278.1K7$1.6M8$4.1M3$1.8M3
Gross profit$78.3K4$263.1K5$1.7M6$1.4M7$3.0M8$2.6M3$358.7K3
Research and development$37.0K4$75.0K5$150.0K6$165.0K6
Selling, general and admin$675.3K8$926.7K8
Operating income-$712.8K4-$3.4M5-$5.9M6-$7.5M7-$10.3M8-$14.2M3-$7.5M3
Interest$279.2K4$263.5K5$8.8K6$934.7K7$2.1M8$902.1K3$2.5M3
Income tax-$748.9K11$2.1K6$3.3K7$1.1K8$7933$9.6K3
Net income-$2.1M4-$4.1M5-$5.9M6-$8.9M7-$12.2M8-$14.9M3-$9.7M3
Earnings per share-$2.876-$1.626-$9.068-$4.183-$0.773
Earnings per share (diluted)-$2.206-$1.366-$4.183-$0.773

Compare Can B Corp with another company

Former names

  • Canbiola, Inc.May 12, 2017 to Mar 3, 20202
  • Wrapmail, Inc.Jan 10, 2011 to May 15, 20172

Recent filings

  1. Jul 16, 202515-12G
  2. Mar 28, 2025NT 10-K
  3. Jan 24, 2025EFFECT
  4. Jan 13, 2025POS AM
  5. Nov 19, 202410-Q
  6. Nov 14, 2024SC 13G/A
  7. Nov 13, 2024NT 10-Q
  8. Oct 28, 20248-K
  9. Oct 28, 202415-12G
  10. Aug 19, 202410-Q
  11. Aug 14, 2024NT 10-Q
  12. Jul 17, 202410-Q/A
  13. Jun 18, 20248-K
  14. May 31, 20248-K
  15. May 20, 202410-Q

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11